1-9 of 9
Anna Lübking
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Isolated myelosarcoma is characterized by recurrent NFE2 mutations and concurrent preleukemic clones in the bone marrow

Vladimir Lazarevic, Christina Orsmark-Pietras, Henrik Lilljebjörn, Louise Pettersson, Marianne Rissler, Anna Lübking, Mats Ehinger, Gunnar Juliusson, Thoas Fioretos
Journal: Blood
Blood (2018) 131 (5): 577–581.
https://doi.org/10.1182/blood-2017-07-793620
Published: 2018
Includes: Supplemental data
Journal Articles

Effects of Dasatinib and Interferon-α Combination Treatment on the Immune System in CML

Mette Ilander, PhD, Hanna Lähteenmäki, MSc, Ulla Olsson-Stromberg, MD PhD, Jesper Stentoft, MD PhD, Johan Richter, MD, Perttu Koskenvesa, MD, Martin Höglund, MD PhD, Arta Dreimane, MD PhD, Kimmo Porkka, MD PhD, Tobias Gedde-Dahl, Björn T. Gjertsen, Franz X. Gruber, Leif Stenke, MD PhD, Kristina Myhr-Eriksson, MD, Berit Markevärn, MD, Anna Lubking, MD, Hanne Vestergaard, MD PhD, Lene Udby, MD, Ole Weis Bjerrum, MD, Henrik Hjorth-Hansen, MD PhD, Satu Mustjoki, MD PhD
Journal: Blood
Blood (2016) 128 (22): 627.
https://doi.org/10.1182/blood.V128.22.627.627
Published: 2016
Journal Articles

Safety and Efficacy of Addition of Pegylated Interferon alpha2b to Standard Dose Dasatinib in Newly Diagnosed Chronic Phase CML Patients

Henrik Hjorth-Hansen, MD PhD, Jesper Stentoft, Johan Richter, MD PhD, Perttu Koskenvesa, MD, Arta Dreimane, MD, Kimmo Porkka, MD PhD, Tobias Gedde-Dahl, MDPhD, Bjorn Gjertsen, MD PhD, Franz X. Gruber, MDPhD, Martin Hoglund, MD PhD, Anna Lubking, MD, Kristina Myhr-Eriksson, MD, Berit Markevärn, Hanne Vestergaard, MDPhD, Ole Weis Bjerrum, MDPhD, Leif Stenke, MDPhD, Satu Mustjoki, MD PhD, Ulla Stromberg, MDPhD
Journal: Blood
Blood (2015) 126 (23): 477.
https://doi.org/10.1182/blood.V126.23.477.477
Published: 2015
Journal Articles

Mature, Adaptive-like CD56 DIM NK Cells in Chronic Myeloid Leukemia Patients in Treatment Free Remission

Mette Ilander, Heinrich Schlums, Ulla Olsson-Strömberg, Hanna Lähteenmäki, Tiina Kasanen, Perttu Koskenvesa, MD, Stina Söderlund, Martin Höglund, Ass Prof, Berit Markevärn, Anders Själander, Kourosh Lotfi, Claes Malm, Anna Lubking, MD, Marja Ekblom, Elena Holm, Mats Björeman, Sören Lehmann, Leif Stenke, MD PhD, Lotta Ohm, Waleed Majeed, MD, Martin C. Muller, Hans Ehrencrona, Henrik Hjorth-Hansen, MD PhD, Susanne Saussele, Francois-Xavier Mahon, MD PhD Professor, Kimmo Porkka, MD PhD, Joelle Guilhot, PhD, Yenan Bryceson, Johan Richter, MD PhD, Satu Mustjoki, MD PhD
Journal: Blood
Blood (2015) 126 (23): 343.
https://doi.org/10.1182/blood.V126.23.343.343
Published: 2015
Journal Articles

Limited Efficacy of Ponatinib in Myeloproliferative Neoplasms Associated with FGFR1 Fusion Genes

Sebastian Kreil, MD PhD, Lionel Adès, MD PhD, Martin Bommer, MD, Frank Stegelmann, MD, Mark E Ethell, MBBChir, MA, FRCP, FRCPath, Anna Lubking, MD, Peter Martin, MD, Ekkehard Eigendorff, MD, Wolf-Karsten Hofmann, MD, Nicholas C.P. Cross, PhD, Andreas Hochhaus, MD, Andreas Reiter, MD
Journal: Blood
Blood (2015) 126 (23): 2812.
https://doi.org/10.1182/blood.V126.23.2812.2812
Published: 2015
Journal Articles

Early Disease Relapse after Tyrosine Kinase Inhibitor Treatment Discontinuation in CML Is Related Both to Low Number and Impaired Function of NK-Cells

Mette Matilda Ilander, MSc, Ulla Olsson-Strömberg, MD PhD, Hanna Lähteenmäki, MSc, Kasanen Tiina, Perttu Koskenvesa, MD, Stina Söderlund, MD, Martin Höglund, MDPhD, Berit Markevärn, MD, Anders Själander, MD PhD, Kourosh Lotfi, MDPhD, Claes Malm, MD, Anna Lubking, MD, Marja Ekblom, MD PhD, Elena Holm, MD, Mats Björeman, MD, Sören Lehmann, MD PhD, Leif Stenke, MD PhD, Lotta Ohm, MD PhD, Waleed Majeed, MD, Markus Pfirrmann, PhD, Martin C Muller, MD, Joelle Guilhot, PhD, Hans Ehrencrona, MD PhD, Henrik Hjorth-Hansen, MD PhD, Susanne Saussele, Francois-Xavier Mahon, MD PhD, Kimmo Porkka, MD PhD, Johan Richter, MD PhD, Satu Mustjoki, MDPhD
Journal: Blood
Blood (2014) 124 (21): 812.
https://doi.org/10.1182/blood.V124.21.812.812
Published: 2014
Journal Articles

Disease Relapse After TKI Discontinuation In CML Is Related Both To Low Number and Impaired Function Of NK-Cells:Data From Euro-SKI

Mette Matilda Ilander, MSc, Ulla Olsson-Strömberg, MD, PhD, Hanna Lähteenmäki, MSc, Tiina Kasanen, Perttu Koskenvesa, MD, Stina Söderlund, MD, Martin Hoglund, MD, PhD, Berit Markevärn, MD, Anders Själander, MD, PhD, Kourosh Lofti, MD, PhD, Claes Malm, MD, Anna Lubking, MD, Marja Ekblom, MD, PhD, Elena Holm, MD, Mats Björeman, MD, Sören Lehmann, MD, PhD, Leif Stenke, MD, PhD, Lotta Ohm, MD, Henrik Hjorth-Hansen, MD, PhD, Susanne Saussele, MD, Francois-Xavier Mahon, MD, PhD, Kimmo Porkka, MD, PhD, Johan Richter, MD, PhD, Satu Mustjoki, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 379.
https://doi.org/10.1182/blood.V122.21.379.379
Published: 2013
Journal Articles

FLT3 ligand and not TSLP is the key regulator of IL-7–independent B-1 and B-2 B lymphopoiesis

Christina T. Jensen, Shabnam Kharazi, Charlotta Böiers, Min Cheng, Anna Lübking, Ewa Sitnicka, Sten Eirik W. Jacobsen
Journal: Blood
Blood (2008) 112 (6): 2297–2304.
https://doi.org/10.1182/blood-2008-04-150508
Published: 2008
Journal Articles

Permissive roles of hematopoietin and cytokine tyrosine kinase receptors in early T-cell development

Christina T. Jensen, Charlotta Böiers, Shabnam Kharazi, Anna Lübking, Tobias Rydén, Mikael Sigvardsson, Ewa Sitnicka, Sten Eirik W. Jacobsen
Journal: Blood
Blood (2008) 111 (4): 2083–2090.
https://doi.org/10.1182/blood-2007-08-108563
Published: 2008
Includes: Supplemental data